期刊
JOURNAL OF CONTROLLED RELEASE
卷 193, 期 -, 页码 228-240出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2014.04.055
关键词
Dry powder inhaler; Pharmaceutical aerosol; Lung deposition; SPECT imaging; Pulmonary drug delivery; Dry powder formulation
资金
- Australian Research Council's Discovery Projects funding scheme [DP120102778, DP110105161]
The efficacy of pharmaceutical aerosols relates to its deposition in the clinically relevant regions of the lungs, which can be assessed by in vivo lung deposition studies. Dry powder formulations are popular as devices are portable and aerosolisation does not require a propellant. Over the years, key advancements in dry powder formulation, device design and our understanding on the mechanics of inhaled pharmaceutical aerosol have opened up new opportunities in treatment of diseases through pulmonary drug delivery. This review covers these advancements and future directions for inhaled dry powder aerosols. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据